WO2022045452A1 - Functional coffee composition and capsule coffee comprising same - Google Patents

Functional coffee composition and capsule coffee comprising same Download PDF

Info

Publication number
WO2022045452A1
WO2022045452A1 PCT/KR2020/015675 KR2020015675W WO2022045452A1 WO 2022045452 A1 WO2022045452 A1 WO 2022045452A1 KR 2020015675 W KR2020015675 W KR 2020015675W WO 2022045452 A1 WO2022045452 A1 WO 2022045452A1
Authority
WO
WIPO (PCT)
Prior art keywords
coffee
extract
functional
germinated
prepared
Prior art date
Application number
PCT/KR2020/015675
Other languages
French (fr)
Korean (ko)
Inventor
오태균
이채원
Original Assignee
네오라이프 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 네오라이프 주식회사 filed Critical 네오라이프 주식회사
Publication of WO2022045452A1 publication Critical patent/WO2022045452A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00Coffee; Coffee substitutes; Preparations thereof
    • A23F5/24Extraction of coffee; Coffee extracts; Making instant coffee
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00Coffee; Coffee substitutes; Preparations thereof
    • A23F5/02Treating green coffee; Preparations produced thereby
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00Coffee; Coffee substitutes; Preparations thereof
    • A23F5/04Methods of roasting coffee
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00Coffee; Coffee substitutes; Preparations thereof
    • A23F5/08Methods of grinding coffee
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00Coffee; Coffee substitutes; Preparations thereof
    • A23F5/24Extraction of coffee; Coffee extracts; Making instant coffee
    • A23F5/243Liquid, semi-liquid or non-dried semi-solid coffee extract preparations; Coffee gels; Liquid coffee in solid capsules
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00Coffee; Coffee substitutes; Preparations thereof
    • A23F5/24Extraction of coffee; Coffee extracts; Making instant coffee
    • A23F5/26Extraction of water-soluble constituents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00Coffee; Coffee substitutes; Preparations thereof
    • A23F5/24Extraction of coffee; Coffee extracts; Making instant coffee
    • A23F5/26Extraction of water-soluble constituents
    • A23F5/267Extraction of water-soluble constituents using additives, specific extraction media or specific coffee blends
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38Other non-alcoholic beverages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38Other non-alcoholic beverages
    • A23L2/382Other non-alcoholic beverages fermented
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F5/00Softening water; Preventing scale; Adding scale preventatives or scale removers to water, e.g. adding sequestering agents
    • C02F5/08Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F5/00Softening water; Preventing scale; Adding scale preventatives or scale removers to water, e.g. adding sequestering agents
    • C02F5/08Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents
    • C02F5/083Mineral agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/02Antioxidant
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/21Plant extracts

Definitions

  • the present invention relates to a functional coffee composition and capsule coffee containing the same, and more specifically, to a coffee bean extract comprising a germinated coffee bean extract germinated using sulfuric water and a lactic acid bacterium fermented blossom mushroom extract, anticancer, anti-inflammatory, It relates to a coffee composition having functions such as antibacterial, antioxidant and immunity enhancement, and capsule coffee comprising the same.
  • the present invention provides a method for producing coffee capsules, wherein the functional coffee composition is in liquid or powder form.
  • the present invention provides capsule coffee prepared by the method for producing capsule coffee according to the above.
  • FIG. 2 is a diagram showing another result of Experimental Example 3 of the present invention, and is a diagram showing an increase in tumor volume for murine B16F10 melanoma cell-related cancer compared to a control group and an experimental group.
  • the coffee bean extract may be performed through a coffee bean extraction method.
  • the method for extracting coffee beans may include a second step of washing the germinated green coffee beans with purified water and then dehydrating them to obtain germinated coffee beans.
  • the present invention is followed by dry fermentation after inoculation of lactic acid bacteria in oyster mushroom. Dry fermentation made in a solid state is advantageous because the present invention uses the extracts of the flower mushrooms, and if the flower mushrooms are pulverized and cultured in liquid, the specific efficacy of the flower mushrooms may disappear.
  • Dry fermentation according to the present invention is performed by adding lactic acid bacteria, preferably Lactobacillus plantarum, to the collected cauliflower mushrooms 1 ⁇ 10 5 to 1 ⁇ 10 10 CFU/g, preferably 1 ⁇ 10 8 to 1 ⁇ 10 9 CFU/g After inoculation at a concentration of g, it can be carried out at 40°C to 60°C for 20 to 24 hours, preferably at 40°C to 50°C for 22 to 24 hours.
  • lactic acid bacteria preferably Lactobacillus plantarum
  • Lactobacillus plantarum KCTC3108 (hereinafter, L. plantarum) strain received from the Gene Bank (Korean Collection for Type Cultures, KCTC, Jeongeup, Korea) of the Korea Research Institute of Bioscience and Biotechnology was used.
  • MRS medium (Difco, Detroit, MI, USA) was used first.
  • L. plantarum was inoculated into 5 ml of MRS medium and cultured for 24 hours in an incubator (SIF500, Jeiotech, Inc., Daejeon, Korea), washed with sterile physiological saline (NaCl 8.5 g/L), and 5 ml of the same solution diluted in Then, 2 ml of the dilution was inoculated into 200 ml of the edible medium, and then enriched and cultured for 24 hours at 37° C. and 100 rpm.
  • the dried oyster mushroom was put back into the oven and left for about 3 minutes from 220°C until the internal temperature dropped to 100°C, and then roasted for about 3 minutes while raising the temperature again to 200°C. Extraction of the roasted oyster mushroom was crushed to a size of 2 mm, and 250 g of the pulverized oyster mushroom was extracted using 2L of purified water for 10 hours. After the extraction was completed, the sample was refrigerated at -4°C and used to prepare the following coffee bean extract.
  • the antioxidant activity showed a tendency to increase as the concentration increased in all experimental groups, and it was confirmed that the highest concentration of 50.0 ⁇ M exhibited a high DPPH scavenging ability of 95% or more.
  • murine B16F10 melanoma cells which are known to cause cancer in vivo, were injected into the abdominal cavity of C57BL/6J mice to induce cancer.
  • the tumor volume (the volume of the tumor) was measured for 21 days, and is shown in FIG. 2 .
  • the coffee bean extract of Example 3 was fed, and the coffee bean extract of Comparative Example 5 was used as a control.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hydrology & Water Resources (AREA)
  • Environmental & Geological Engineering (AREA)
  • Water Supply & Treatment (AREA)
  • Organic Chemistry (AREA)
  • Tea And Coffee (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a functional coffee composition and capsule coffee comprising same and, more specifically, to a coffee composition comprising a coffee bean extract including: an extract from coffee beans germinated with Jewhangsu; and a lactic acid bacterium-fermented Sparassis crispa extract, and having functionalities such as anticancer, anti-inflammatory, antibacterial, antioxidant activities and immunopotentiation, and capsule coffee comprising same.

Description

기능성 커피 조성물 및 이를 포함하는 캡슐 커피Functional coffee composition and capsule coffee comprising same
본 발명은 기능성 커피 조성물 및 이를 포함하는 캡슐 커피에 관한 것으로, 보다 구체적으로 제황수를 이용하여 발아시킨 발아커피원두 추출물 및 유산균 발효된 꽃송이 버섯 추출물을 포함하는 커피원두 추출물을 포함하여 항암, 항염, 항균, 항산화 및 면역력 강화 등의 기능성을 가진 커피 조성물과 이를 포함하는 캡슐 커피에 관한 것이다.The present invention relates to a functional coffee composition and capsule coffee containing the same, and more specifically, to a coffee bean extract comprising a germinated coffee bean extract germinated using sulfuric water and a lactic acid bacterium fermented blossom mushroom extract, anticancer, anti-inflammatory, It relates to a coffee composition having functions such as antibacterial, antioxidant and immunity enhancement, and capsule coffee comprising the same.
일반적으로, 커피 원두란 빨간 열매 중에 있는 종자로 열매 속에 2개의 종자가 마주 보고 있으며, 이 종자를 탈곡 후 건조시켜 정제한 것을 원두라고 한다. 이 원두는 로스팅 과정을 거친 후 커피 고유의 향과 맛을 가지게 된다. 커피는 수분, 단백질, 탄닌, 카페인 등 다양한 성분을 함유하고 있어 인체에 여러 생리적 영향을 미치는데, 그 주요 성분은 카페인으로 카페인은 부신 피질 호르몬 분비를 활성화시켜 순환기 계통의 운동을 늘리고 이뇨작용을 유발하며, 기관지 확장, 위장관 운동성을 증가시키는 등의 효과를 나타낸다. 또한, 중추신경 흥분제로 작용하는데, 두 잔 정도의 커피는 수행 능력의 향상을 가져오고 피로를 줄이며, 공격 성향 등을 줄인다고 한다.In general, coffee beans are the seeds in the red fruit, and two seeds face each other in the fruit. After threshing, drying and refining the seeds are called coffee beans. These beans have a unique aroma and taste after the roasting process. Coffee contains various components such as water, protein, tannin, and caffeine, which have various physiological effects on the human body. It shows effects such as bronchodilation and gastrointestinal motility. In addition, it acts as a central nervous system stimulant, and about two cups of coffee is said to improve performance, reduce fatigue, and reduce aggression.
커피의 다양한 생리활성은 많은 연구를 통해 알려져 있으며 그 중 항산화에 대한 연구로는 다양한 음료에서 페놀 화합물의 함량을 측정한 결과 레드와인보다 커피의 페놀 함량이 높은 것으로 나타났으며, 자유기와 바이러스 감염의 해로운 활동을 막는 효과를 가지고 있다는 결과와 커피의 섭취가 LDL의 산화에 대한 감수성을 줄임으로서 LDL-콜레스테롤과 MDA(Malondialdehyde)를 줄인다는 보고가 있다.The various physiological activities of coffee are known through many studies. Among them, as a result of measuring the content of phenolic compounds in various beverages, the study on antioxidants showed that the phenolic content of coffee was higher than that of red wine. There are reports that it has the effect of preventing harmful activity and that consumption of coffee reduces LDL-cholesterol and MDA (Malondialdehyde) by reducing the sensitivity to oxidation of LDL.
하지만, 커피는 하루 섭취량을 초과하여 마시거나, 산화된 원두로 제조된 커피를 마시거나, 인스턴트의 믹스 커피 첨가물인 설탕과 프림 등을 섞은 것들을 마실 경우, 커피의 순기능은 없어지고 오히려 건강상의 문제를 유발할 수 있다. 뿐만 아니라, 커피는 카페인 이외에도 1000여가지 정도의 화학물질이 있는데 그 중에 20여가지는 쥐 실험 결과 발암 물질로 확인되어, 세계보건기구(WHO)에서는 커피를 3단계 발암물질로까지 규정하고 있다.However, if you drink coffee in excess of the daily intake, drink coffee made from oxidized coffee beans, or drink a mixture of instant mixed coffee additives such as sugar and cream, the pure function of coffee is lost and rather health problems are caused. can cause In addition, coffee contains about 1,000 chemical substances other than caffeine, and 20 of them have been confirmed as carcinogens as a result of a mouse experiment, and the World Health Organization (WHO) defines coffee as a level 3 carcinogen.
한편, 꽃송이버섯(Sparassis crispa)은 담자균류 민주름버섯목 꽃송이버섯과의 버섯으로, 자실체(子實體)는 육질(肉質)로 가장자리가 물결 모양이다.On the other hand, Sparassis crispa is a mushroom of the basidiomycete Minorus serrata family, and the fruiting body is fleshy and has a wavy edge.
꽃송이버섯은 베타글루칸(β-glucan)을 다량 함유하여 항암 효과가 있는 것으로 알려져 있다(Ohno N, Miura NN, Nakajima M, Yadomae T. 2000. Antitumor 1, 3- β-Glucan from Cultured Fruit Body of Sparassis crispa. Biol Pharm Bull 23: 866-872). 또한, 꽃송이버섯은 베타글루칸과 더불어 베라트르산(veratric acid)과 같은 페놀계 화합물이 다른 버섯에 비해 풍부한 것으로 알려져 있다(Kim MY, Seguin P, Ahn JK, Kim JJ, Chun SC, Kim EH, Seo SH, Kang EY, Kim SL, Park YJ, Ro HM, Chung IM. 2008. Phenolic compound concentration and antioxidant activities of edible and medicinal mushrooms from Korea. J Agric Food Chem 56: 7265-7270).Oyster mushroom contains a large amount of beta-glucan and is known to have anticancer effects (Ohno N, Miura NN, Nakajima M, Yadomae T. 2000. Antitumor 1, 3- β-Glucan from Cultured Fruit Body of Sparassis) crispa. Biol Pharm Bull 23: 866-872). In addition, oyster mushroom is known to be rich in phenolic compounds such as veratric acid as well as beta-glucan compared to other mushrooms (Kim MY, Seguin P, Ahn JK, Kim JJ, Chun SC, Kim EH, Seo). SH, Kang EY, Kim SL, Park YJ, Ro HM, Chung IM. 2008. Phenolic compound concentration and antioxidant activities of edible and medicinal mushrooms from Korea. J Agric Food Chem 56: 7265-7270).
버섯에 포함된 베타글루칸과 같은 다당류는 인체 내의 소화 효소로는 분해되지 않고 또한 열수 추출할 경우 수율이 떨어지는데 이를 보완할 수 있는 기술 중 하나가 발효를 시키는 것이다.Polysaccharides such as beta-glucan contained in mushrooms are not decomposed by digestive enzymes in the human body, and yield drops when hot water extraction is performed. One of the technologies that can compensate for this is fermentation.
이에, 본 발명의 발명자는 꽃송이버섯을 유산균 발효를 한 다음 추출한 꽃송이버섯 추출물을 커피원두 추출물에 포함시킴으로써, 항암, 항염, 항산화 및 면역력 강화 등의 기능성을 부여한 커피 조성물을 제조할 수 있음을 확인하고 본 발명에 이르렀다.Accordingly, the inventors of the present invention confirm that it is possible to prepare a coffee composition with functions such as anti-cancer, anti-inflammatory, antioxidant and immunity enhancement by including the flower mushroom extract extracted after lactic acid bacteria fermentation of the flower mushroom in the coffee bean extract, and came to the present invention.
[선행기술문헌][Prior art literature]
[특허문헌][Patent Literature]
특허문헌 1: 한국 등록특허공보 제10-1520332호 (2015.05.08 등록)Patent Document 1: Korean Patent Publication No. 10-1520332 (registration on May 8, 2015)
특허문헌 2: 한국 등록특허공보 제10-1183775호 (2012.09.11 등록)Patent Document 2: Korean Patent Publication No. 10-1183775 (Registered on September 11, 2012)
본 발명자들은 상기 종래 기술의 문제점 해결하기 위하여, 보다 항암, 항염, 항산화 및 면역력 강화의 기능성을 가진 기능성 커피 조성물을 제공하고자 꽃송이버섯을 포함하되 상기 꽃송이버섯에 대한 유산균 발효를 시킨 꽃송이버섯에 대한 추출물을 포함하고, 추가적으로 제황수를 이용하여 발아시킨 커피 원두 분말 및 액상 추출물을 포함할 경우, 커피로서의 풍미나 향은 유지하면서, 기능성이 한층 강화되었다는 점을 확인함으로써, 보다 항암, 항염, 항균, 항산화 및 면역력 강화의 기능성이 강화된 기능성 커피 조성물을 제공하고자 한다.In order to solve the problems of the prior art, the present inventors include oyster mushroom to provide a functional coffee composition having more anti-cancer, anti-inflammatory, antioxidant and immune strengthening functions, but extract for oyster mushroom after lactic acid ferment for the oyster mushroom In addition, when including coffee bean powder and liquid extract germinated using sulfuric water, it is confirmed that the functionality is further enhanced while maintaining the flavor and aroma of coffee, and thus more anti-cancer, anti-inflammatory, antibacterial, and antioxidant And to provide a functional coffee composition with enhanced immunity strengthening function.
본 발명은, 상기 언급한 과제 해결을 위하여,The present invention, in order to solve the above-mentioned problems,
커피원두 추출물을 포함하는 기능성 커피 조성물에 있어서,In the functional coffee composition comprising a coffee bean extract,
상기 커피원두 추출물은 제황수를 이용하여 발아시킨 발아커피원두 추출물 및 유산균 발효된 꽃송이 버섯 추출물을 포함하고,The coffee bean extract includes a germinated coffee bean extract germinated using sulfuric water and a lactic acid bacteria fermented flower mushroom extract,
상기 조성물은, 하기 중 하나 이상의 특성을 포함하는 기능성 커피 조성물을 제공한다.The composition provides a functional coffee composition comprising one or more of the following properties.
i) 항암;i) anticancer;
ii) 항염;ii) anti-inflammatory;
iii) 항균;iii) antibacterial;
iv) 항산화; 및iv) antioxidant; and
v) 면역력 강화.v) strengthening immunity.
또한, 본 발명은, 상기 제황수는 광물 유황을 세척하여 준비하는 단계;In addition, the present invention, the sulfuric water is prepared by washing the mineral sulfur;
상기 준비된 광물 유황을 0.5㎛ 이하로 분쇄하는 단계; 및pulverizing the prepared mineral sulfur to 0.5 μm or less; and
상기 분쇄된 광물 유황을 정제수와 혼합하는 단계를 포함하는 제황수 제조방법에 의해 제조된 것을 특징으로 하는 기능성 커피 조성물을 제공한다. It provides a functional coffee composition, characterized in that produced by a method for producing sulfuric water comprising the step of mixing the pulverized mineral sulfur with purified water.
또한, 본 발명은, 상기 발아커피원두 추출물은, In addition, the present invention, the germinated coffee bean extract,
1) 커피생두를 고루 펼친 상태에서 0.3㎛ 또는 0.5㎛의 분쇄 광물 유황 0.1 중량% 또는 0.2 중량% 각각에 대하여 정제수 99.9 중량% 및 99.8 중량%를 혼합하여 혼합물을 제조하는 단계;1) preparing a mixture by mixing 99.9% by weight and 99.8% by weight of purified water with respect to 0.1% by weight or 0.2% by weight of pulverized mineral sulfur of 0.3 μm or 0.5 μm, respectively, in a state in which green coffee beans are evenly spread;
2) 상기 제조된 혼합물에 제황수를 하루 동안 4번 또는 5번 정도 살수하여 발아시킨 발아커피원두를 제조하는 단계;2) preparing germinated coffee beans by spraying the prepared mixture with sulfuric water 4 or 5 times a day;
3) 상기 제조된 발아커피원두를 세척, 건조 및 로스팅 후 분쇄시켜 커피원두를 제조하는 단계; 및3) washing, drying and roasting the prepared germinated coffee beans and then pulverizing them to prepare coffee beans; and
4) 상기 제조된 커피원두를 온도 90℃ 또는 150℃의 물을 첨가하여 추출하여 커피원두 추출물을 제조하는 단계를 포함하는 발아커피원두 추출물 제조방법에 의해 제조된 것을 특징으로 하는 기능성 커피 조성물을 제공한다.4) Providing a functional coffee composition, characterized in that it is prepared by a method for producing a germinated coffee bean extract comprising the step of extracting the prepared coffee beans by adding water at a temperature of 90 °C or 150 °C to prepare a coffee bean extract do.
또한, 본 발명은, 상기 유산균 발효된 꽃송이 버섯 추출물은, In addition, the present invention, the lactic acid bacteria fermented chrysanthemum mushroom extract,
1) 꽃송이 버섯에 멸균 증류수를 첨가하여 발효에 필요한 수분을 흡수시키는 단계;1) adding sterile distilled water to the oyster mushroom to absorb moisture required for fermentation;
2) 단계 1)에서 수득된 꽃송이 버섯에 글루코스를 첨가하고 유산균을 접종하여 건식 발효를 수행하는 단계;2) performing dry fermentation by adding glucose to the flower mushroom obtained in step 1) and inoculating lactic acid bacteria;
3) 발효가 끝난 꽃송이 버섯을 세척하고 건조시킨 후 배전 및 분쇄하는 단계; 및3) washing, drying, roasting and pulverizing the fermented zinnia mushrooms; and
4) 단계 3)에서 수득된 꽃송이 버섯 분말을 물로 추출하여 유산균 발효 꽃송이 버섯 추출물을 수득하는 단계를 포함하는 유산균 발효된 꽃송이 버섯 추출물 제조방법에 의해 제조된 것을 특징으로 하는 기능성 커피 조성물을 제공한다.4) Extracting the flower mushroom powder obtained in step 3) with water to obtain a lactic acid bacterium fermented flower mushroom extract It provides a functional coffee composition, characterized in that it is prepared by the method for preparing the extract.
또한, 본 발명은, 상기 2) 단계는 락토바실러스 플란타룸 (Lactobacillus plantarum), 락토바실러스 람노서스 (Lactobacillus rhamnosus), 락토바실러스 에시도필러스 (Lactobacillus acidophilus), 락토바실러스 불가리커스 (Lactobacillus bulgaricus), 바실러스 코아그란스 (Bacillus coagulans), 및 비피도박테리아 롱검 (BifidobacteriumLongum)으로 이루어진 군으로부터 선택된 1종 이상의 유산균으로 발효한 것을 특징으로 하는 기능성 커피 조성물을 제공한다.In addition, in the present invention, step 2) is Lactobacillus plantarum (Lactobacillus plantarum), Lactobacillus rhamnosus (Lactobacillus rhamnosus), Lactobacillus acidophilus (Lactobacillus acidophilus), Lactobacillus bulgaricus (Lactobacillus bulgaricus), Bacillus coagulans (Bacillus coagulans), and provides a functional coffee composition, characterized in that fermented with one or more lactic acid bacteria selected from the group consisting of Bifidobacterium Longum (Bifidobacterium Longum).
또한, 본 발명은, 상기 커피원두 추출물은, 전체 100 중량부 기준으로 발아커피원두 추출물 1 중량부 내지 15 중량부 및 유산균 발효된 꽃송이 버섯 추출물 5 중량부 내지 20 중량부를 포함하는 것을 특징으로 하는 기능성 커피 조성물을 제공한다. In addition, the present invention, the coffee bean extract, based on 100 parts by weight in total, 1 part by weight to 15 parts by weight of the germinated coffee bean extract and 5 parts by weight to 20 parts by weight of the lactic acid bacterium fermented blossom mushroom extract Functional A coffee composition is provided.
또한, 본 발명은, 상기 기능성 커피 조성물을 캡슐(capsule)에 충진시키고, 상기 캡슐의 캡을 씌워 내부 성분이 유출되지 않도록 밀봉하는 단계를 포함하는 캡슐 커피의 제조방법을 제공한다. In addition, the present invention provides a method for producing coffee capsules comprising the step of filling a capsule (capsule) with the functional coffee composition, and sealing the capsule so that the internal components do not leak by covering the cap.
또한, 본 발명은, 상기 기능성 커피 조성물은, 액상 또는 분말 형태인 것을 특징으로 하는 캡슐 커피의 제조방법을 제공한다.In addition, the present invention provides a method for producing coffee capsules, wherein the functional coffee composition is in liquid or powder form.
또한, 본 발명은, 상기 밀봉은 1bar 내지 20bar의 기압을 넣어서, 수행하는 것을 특징으로 하는 캡슐 커피의 제조방법을 제공한다.In addition, the present invention provides a method for producing coffee capsules, characterized in that the sealing is performed by putting an air pressure of 1 bar to 20 bar.
또한, 본 발명은, 상기 따른 캡슐 커피의 제조방법으로 제조된 캡슐 커피를 제공한다.In addition, the present invention provides capsule coffee prepared by the method for producing capsule coffee according to the above.
본 발명에 따른 기능성 커피 조성물은, 꽃송이버섯을 포함하되 상기 꽃송이버섯에 대한 유산균 발효를 시킨 꽃송이버섯에 대한 추출물을 포함하고, 추가적으로 제황수를 이용하여 발아시킨 발아커피원두 추출물을 포함함으로써, 커피 본연의 풍미나 향은 유지하면서 동시에 보다 항암, 항염, 항균, 항산화 및 면역력 강화 등의 효능이 높은 커피를 제공할 수 있다. 또한, 본 발명에 따른 기능성 커피 조성물은, 높은 압력을 통한 가공에도 안정성을 유지할 수 있어, 캡슐 커피로 수월하게 제공될 수 있다.The functional coffee composition according to the present invention includes a flower mushroom, but contains an extract for the flower mushroom, which is fermented with lactic acid bacteria for the flower mushroom, and additionally contains a germinated coffee bean extract germinated using jesulfite water. It is possible to provide coffee with higher efficacy, such as anti-cancer, anti-inflammatory, antibacterial, antioxidant, and immunity enhancement, while maintaining the flavor and aroma of the coffee. In addition, the functional coffee composition according to the present invention can maintain stability even in processing through high pressure, and thus can be easily provided as coffee capsules.
첨부된 도면은 해당 기술 분야의 통상의 기술자에게 본 발명의 내용을 보다 상세하게 설명하기 위한 것으로 본 발명의 기술적 사상이 이에 한정되는 것은 아니다. The accompanying drawings are intended to explain the contents of the present invention in more detail to those skilled in the art, but the technical spirit of the present invention is not limited thereto.
도 1은, 본 발명의 실험예 3에 대한 결과를 나타낸 도이다.1 is a view showing the results for Experimental Example 3 of the present invention.
도 2는, 본 발명의 실험예 3에 대한 또 다른 결과를 나타낸 도로서, murine B16F10 melanoma세포 관련 암에 대한 종양 부피의 증가를 대조군과 실험군으로 비교하여 나타낸 도이다.2 is a diagram showing another result of Experimental Example 3 of the present invention, and is a diagram showing an increase in tumor volume for murine B16F10 melanoma cell-related cancer compared to a control group and an experimental group.
도 3은, 본 발명의 실험예 4에서 커피 원두 추출물을 첨가한 후의 TNF-α 분비량에 대하여 β-glucan을 첨가한 후의 TNF-α 분비량과 비교하기 위한 도이다.3 is a diagram for comparing the secretion amount of TNF-α after the addition of β-glucan with respect to the secretion amount of TNF-α after adding the coffee bean extract in Experimental Example 4 of the present invention.
이하, 본 발명에 따른 기능성 커피 조성물, 캡슐 커피의 제조방법 및 상기 캡슐 커피의 제조방법으로부터 제조된 캡슐 커피에 관하여 상세히 설명하나, 상기 기능성 커피 조성물, 캡슐 커피의 제조방법 및 상기 캡슐 커피의 제조방법으로부터 제조된 캡슐 커피의 권리범위는 하기 설명에 의해 제한되는 것은 아니다. Hereinafter, the functional coffee composition according to the present invention, the production method of capsule coffee and the capsule coffee prepared from the capsule coffee production method will be described in detail, but the functional coffee composition, the production method of the capsule coffee and the production method of the capsule coffee The scope of rights of capsule coffee prepared from is not limited by the following description.
명세서 전체에서, 어떤 부분이 어떤 구성요소를 “포함”한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성요소를 제외하는 것이 아니라 다른 구성요소를 더 포함할 수 있는 것을 의미한다. Throughout the specification, when a part "includes" a certain component, it means that other components may be further included, rather than excluding other components, unless otherwise stated.
또한, 본 명세서상에서의 용어 '커피원두 추출물'이라 함은, 커피생두 또는 커피원두(커피콩)에 대한 살수 과정을 통하여 발효 또는 발아시키는 과정을 통해 얻어진 발아 커피원두에 대하여 분쇄 후 분쇄된 커피원두와 원두에 대하여 열수 추출하여 얻어진 추출물을 포함하는 의미일 수 있다.In addition, as used herein, the term 'coffee bean extract' refers to coffee beans that have been pulverized after grinding with respect to germinated coffee beans obtained through fermentation or germination through the watering process for green coffee beans or coffee beans (coffee beans). and extracts obtained by hot water extraction of coffee beans.
본 발명은 커피 조성물에 관한 것이고, 보다 구체적으로, 본 발명은 기능성 커피 조성물에 관한 것이다.The present invention relates to a coffee composition, and more particularly, the present invention relates to a functional coffee composition.
본 발명에 따른 기능성 커피 조성물은, 커피원두 추출물을 포함한다.The functional coffee composition according to the present invention includes a coffee bean extract.
상기 커피원두 추출물은 제황수를 이용하여 발아시킨 발아커피원두 추출물 및 유산균 발효된 꽃송이 버섯 추출물을 포함한다.The coffee bean extract includes a germinated coffee bean extract germinated using sulfuric water and a lactic acid bacterium fermented Zinnia mushroom extract.
본 명세서상에서의 용어 '제황수'는 유황을 정제수로 희석하여 독성을 제거한 유황수를 의미할 수 있으며, '제독유황수' 또는 '법제유황수'와 유사한 의미를 가질 수 있다.As used herein, the term 'sulfur water' may mean sulfur water from which toxicity is removed by diluting sulfur with purified water, and may have a similar meaning to 'admiral sulfur water' or 'legal sulfur water'.
상기 제황수는 광물 유황을 세척하여 준비하는 단계; 상기 준비된 광물 유황을 0.5㎛ 이하로 분쇄하는 단계; 및 상기 분쇄된 광물 유황을 정제수와 혼합하는 단계를 포함하는 제황수 제조방법에 의해 제조될 수 있다.Preparing the sulfuric water by washing the mineral sulfur; pulverizing the prepared mineral sulfur to 0.5 μm or less; and mixing the pulverized mineral sulfur with purified water.
상기 광물 유황의 경우 처음 채취될 경우, 이물질이 많이 포함되어 있으므로 세척하는 과정을 통하여 이물질의 포함을 최소화시킬 수 있다.In the case of the mineral sulfur, when it is first collected, since it contains a lot of foreign substances, it is possible to minimize the inclusion of foreign substances through the washing process.
상기 광물 유황을 세척한 후에는 세척된 광물 유황을 약 0.5㎛ 이하, 약 0.25㎛ 이하 또는 약 0.1㎛ 이하의 미세한 분말로 분쇄하는 단계를 수행할 수 있다.After washing the mineral sulfur, a step of pulverizing the washed mineral sulfur into a fine powder of about 0.5 μm or less, about 0.25 μm or less, or about 0.1 μm or less may be performed.
또한, 본 발명에 따른 상기 발아커피원두 추출물은, 1) 커피생두를 고루 펼친 상태에서 0.3㎛ 또는 0.5㎛의 분쇄 광물 유황 0.1 중량% 또는 0.2 중량% 각각에 대하여 정제수 99.9 중량% 및 99.8 중량%를 혼합하여 혼합물을 제조하는 단계; 2) 상기 제조된 혼합물에 제황수를 하루 동안 4번 또는 5번 정도 살수하여 발아시킨 발아커피원두를 제조하는 단계; 3) 상기 제조된 발아커피원두를 세척, 건조 및 로스팅 후 분쇄시켜 커피원두를 제조하는 단계; 및 4) 상기 제조된 커피원두를 온도 90℃ 또는 150℃의 물을 첨가하여 추출하여 커피원두 추출물을 제조하는 단계를 포함하는 발아커피원두 추출물 제조방법에 의해 제조될 수 있다.In addition, the germinated coffee bean extract according to the present invention comprises: 1) 99.9 wt% and 99.8 wt% of purified water with respect to 0.1 wt% or 0.2 wt% of ground mineral sulfur of 0.3 μm or 0.5 μm, respectively, in a state where green coffee beans are evenly spread mixing to prepare a mixture; 2) preparing germinated coffee beans by spraying the prepared mixture with sulfuric water 4 or 5 times a day; 3) washing, drying and roasting the prepared germinated coffee beans and then pulverizing them to prepare coffee beans; and 4) extracting the prepared coffee beans by adding water at a temperature of 90°C or 150°C to prepare a coffee bean extract.
상기 0.3㎛ 또는 0.5㎛의 크기는 상기 광물 유황 입자 1개의 지름의 길이를 의미하며, 입자 지름이 작을수록 후술하는 살수 과정에서의 커피원두에 대한 살수 과정에서의 흡수가 용이하므로 보다 효율적인 커피원두 발아 공정을 진행할 수 있다.The size of 0.3 μm or 0.5 μm means the length of the diameter of one mineral sulfur particle, and the smaller the particle diameter, the easier it is to absorb coffee beans in the watering process to be described later, so more efficient coffee bean germination process can proceed.
또한, 상기 분쇄된 광물 유황을 정제수와 혼합하는 단계는 분쇄된 광물 유황의 독성 제거를 위해 필요한 수준의 정제수의 양과 혼합될 수 있다. 상기 정제수의 양은 특별히 제한되는 것은 아니나, 예를 들어 정제수 99.5 중량% 내지 99.9 중량% 및 분쇄 광물 유황 0.1 중량% 내지 0.5 중량%; 정제수 99.75 중량% 내지 99.9 중량% 및 분쇄 광물 유황 0.1 중량% 내지 0.25 중량%; 또는 정제수 99.8 중량% 내지 99.9 중량% 및 분쇄 광물 유황 0.1 중량% 내지 0.2 중량%일 수 있다.In addition, the step of mixing the pulverized mineral sulfur with purified water may be mixed with an amount of purified water at a level necessary for the removal of toxicity of the pulverized mineral sulfur. Although the amount of the purified water is not particularly limited, for example, 99.5 wt% to 99.9 wt% of purified water and 0.1 wt% to 0.5 wt% of pulverized mineral sulfur; 99.75 wt% to 99.9 wt% purified water and 0.1 wt% to 0.25 wt% pulverized mineral sulfur; Or 99.8 wt% to 99.9 wt% of purified water and 0.1 wt% to 0.2 wt% of pulverized mineral sulfur.
상기 범위내에서의 정제수 및 분쇄 광물 유황의 혼합 비율로 혼합될 경우, 제조된 제황수는 독성이 전혀 없고 커피원두에 대한 항산화 및 면역 기능을 극대화시킬 수 있다.When mixed in a mixing ratio of purified water and pulverized mineral sulfur within the above range, the prepared sulfuric water has no toxicity and can maximize the antioxidant and immune function of coffee beans.
상기 커피원두 추출물은, 커피원두 추출방법을 통하여 수행될 수 있다.The coffee bean extract may be performed through a coffee bean extraction method.
상기 커피원두 추출방법은, 상기 제조된 제황수를 상기 커피원두를 발아시키기 위한 커피생두에 살수하는 제 1 공정을 포함할 수 있다.The method of extracting coffee beans may include a first step of spraying the prepared sulfuric water onto green coffee beans for germinating the coffee beans.
상기 살수를 위한 공정은 특별히 제한되는 것은 아니나, 예를 들어 하루에 4회 내지 5회에 걸쳐 3일간 공급하여 수행하는 공정을 포함할 수 있으며, 어느 정도 발아한 상태의 커피원두는 하루에 4회 내지 5회에 걸쳐 2일간 공급하는 공정을 추가적으로 포함할 수 있다.The process for the watering is not particularly limited, but for example, may include a process of supplying 4 to 5 times a day for 3 days and performing, and the coffee beans in a somewhat germinated state are 4 times a day It may additionally include a process of supplying for 2 days over 5 times.
상기 커피원두 추출방법은, 상기 발아된 커피생두를 정제수로 세척 후 탈수 과정을 거쳐 발아커피원두를 수득하는 제 2 공정을 포함할 수 있다.The method for extracting coffee beans may include a second step of washing the germinated green coffee beans with purified water and then dehydrating them to obtain germinated coffee beans.
발아된 커피생두의 경우 상기 제 1 공정에서의 살수 공정에 의해 이물질이 추가적으로 포함되어 있을 수 있으므로, 정제수로 세척하는 것이 바람직하다.In the case of germinated green coffee beans, foreign substances may be additionally included by the watering process in the first step, so it is preferable to wash them with purified water.
상기 세척 후에는 후술하는 로스팅 과정을 위해 탈수 과정을 별도로 거쳐야 한다.After the washing, a separate dehydration process is required for a roasting process to be described later.
상기 커피원두 추출방법은, 상기 수득된 발아커피원두를 건조하여 로스팅 후, 분쇄하는 제 3 공정을 포함한다.The coffee bean extraction method includes a third step of drying and roasting the obtained germinated coffee beans, followed by pulverization.
상기 제 2 공정에서의 탈수 공정을 통하여 어느 정도의 수분 제거를 마친 발아커피원두의 경우 로스팅 과정 수행 전에 건조 과정을 별도로 수행함으로써 로스팅을 위한 발아커피원두를 준비할 수 있다.In the case of germinated coffee beans that have been removed from moisture to some extent through the dehydration process in the second step, the germinated coffee beans for roasting can be prepared by separately performing a drying process before performing the roasting process.
상기 건조 조건은 특별히 제한되는 것은 아니나, 예를 들어 약 70℃내지 80℃에서 약 5분 내지 10분 자연 건조 또는 열을 가하는 건조 과정으로 수행될 수 있다.The drying conditions are not particularly limited, but for example, natural drying at about 70° C. to 80° C. for about 5 to 10 minutes or a drying process by applying heat may be performed.
상기 건조된 발아커피원두는 로스팅 과정을 통하여, 볶는 과정을 통하여 진행될 수 있으며, 이 경우 로스팅 기계를 사용할 수 있다.The dried germinated coffee beans may be processed through a roasting process and a roasting process, and in this case, a roasting machine may be used.
상기 로스팅 후의 발아커피원두는 분쇄하는 과정을 통하여 분쇄된 커피원두를 수득할 수 있다.The germinated coffee beans after the roasting can be ground to obtain ground coffee beans through the grinding process.
상기 커피원두 추출방법은, 상기 분쇄된 발아커피를 65℃ 내지 120℃, 70℃내지 110℃ 또는 80℃내지 100℃의 물로 열탕 추출하여 커피원두 추출물을 수득하는 제 4 공정을 포함할 수 있다.The coffee bean extraction method may include a fourth step of extracting the ground germinated coffee with hot water at 65 ° C. to 120 ° C., 70 ° C. to 110 ° C. or 80 ° C. to 100 ° C. to obtain a coffee bean extract.
상기 전술한 범위에서의 온도를 가지는 물을 사용할 경우, 보다 분쇄된 커피원두에 대한 추출이 용이하고 효율적으로 진행될 수 있다.When water having a temperature in the above-mentioned range is used, extraction of more pulverized coffee beans can be carried out easily and efficiently.
상기 커피원두 추출물은, 특별히 제한되는 것은 아니나, 예를 들어 상기 커피원두의 발효추출물, 발아추출물, 숙성추출물, 열수추출물 및 유황추출물로 이루어진 군으로부터 선택된 1종 이상인 것을 특징으로 하는 제황수를 이용한 커피원두 추출물일 수 있다.The coffee bean extract is not particularly limited, but for example, coffee using desulfurization water, characterized in that at least one selected from the group consisting of a fermentation extract, a germination extract, a ripening extract, a hot water extract, and a sulfur extract of the coffee beans. It may be a bean extract.
본 발명에 따른 상기 유산균 발효된 꽃송이 버섯 추출물은, 1) 꽃송이 버섯에 멸균 증류수를 첨가하여 발효에 필요한 수분을 흡수시키는 단계; 2) 단계 1)에서 수득된 꽃송이 버섯에 글루코스를 첨가하고 유산균을 접종하여 건식 발효를 수행하는 단계; 3) 발효가 끝난 꽃송이 버섯를 세척하고 건조시킨 후 배전 및 분쇄하는 단계; 및 4) 단계 3)에서 수득된 꽃송이 버섯 분말을 물로 추출하여 유산균 발효 꽃송이 버섯 추출물을 수득하는 단계를 포함하는 유산균 발효된 꽃송이 버섯 추출물 제조방법에 의해 제조될 수 있다.The lactic acid bacterium fermented flower mushroom extract according to the present invention comprises the steps of: 1) adding sterilized distilled water to the flower mushroom to absorb moisture required for fermentation; 2) performing dry fermentation by adding glucose to the flower mushroom obtained in step 1) and inoculating lactic acid bacteria; 3) washing, drying, and roasting and pulverizing the fermented Zinnia mushrooms; And 4) extracting the flower mushroom powder obtained in step 3) with water to obtain a lactic acid bacterium fermented flower mushroom extract.
본 발명에 따른 상기 유산균 발효된 꽃송이 버섯 추출물의 수득은, 먼저 꽃송이 버섯에 멸균 증류수를 첨가하여 발효에 필요한 수분을 흡수시키는 단계를 수행한다.To obtain the lactic acid bacterium fermented flower mushroom extract according to the present invention, first, sterile distilled water is added to the flower mushroom to absorb the moisture required for fermentation.
본 발명의 꽃송이 버섯은 채취한 상태 그대로 유산균과의 건식 발효에 적용된다. 구체적으로, 건식 발효에 적용하기 전에 꽃송이 버섯의 발효에 필요한 수분을 일정 수준 흡수시킨 후 수분이 흡수된 꽃송이 버섯의 무게를 기준으로 1% 내지 10%(w/w)의 글루코스, 바람직하게는 1% 내지 5%(w/w)의 글루코스를 첨가하고 유산균을 접종하여 발효시킨다.The flower mushroom of the present invention is applied to dry fermentation with lactic acid bacteria as it is collected. Specifically, after absorbing a certain level of moisture required for the fermentation of oyster mushroom before applying to dry fermentation, 1% to 10% (w/w) glucose, preferably 1, based on the weight of the oyster mushroom the moisture has been absorbed % to 5% (w/w) of glucose is added and lactic acid bacteria are inoculated and fermented.
보다 구체적인 실시양태로서, 상기 1)단계는, 꽃송이 버섯 100g당 10㎖의 멸균 증류수를 첨가하여 10℃ 내지 60℃에서 0.5시간 내지 5시간 동안 침지시켜 꽃송이 버섯에 수분을 흡수시킨다.As a more specific embodiment, in step 1), 10 ml of sterile distilled water is added per 100 g of oyster mushroom and immersed at 10° C. to 60° C. for 0.5 to 5 hours to absorb moisture into the cypress mushroom.
본 발명의 건식 발효에 사용될 수 있는 유산균으로는 특별히 그 종류를 제한하는 것은 아니나, 바람직하게는 락토바실러스 플란타룸 (Lactobacillus plantarum), 락토바실러스 람노서스 (Lactobacillus rhamnosus), 락토바실러스 에시도필러스 (Lactobacillus acidophilus), 락토바실러스 불가리커스 (Lactobacillus bulgaricus), 바실러스 코아그란스 (Bacillus coagulans), 비피도박테리아 롱검 (BifidobacteriumLongum) 중 어느 하나를 사용할 수 있고, 바람직하게는 락토바실러스 플란타룸을 사용할 수 있다.The lactic acid bacteria that can be used for the dry fermentation of the present invention are not particularly limited, but preferably Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus esidophilus ( Lactobacillus acidophilus), Lactobacillus bulgaricus (Lactobacillus bulgaricus), Bacillus coagulans (Bacillus coagulans), any one of Bifidobacterium Longum (Bifidobacterium Longum) can be used, preferably Lactobacillus plantarum can be used.
본 발명은 꽃송이 버섯에 유산균을 접종한 후 건식 발효시킨다. 본 발명은 꽃송이 버섯 채취물을 사용하기 때문에 고체 상태로 이루어지는 건식 발효가 유리하며, 만약 상기 꽃송이 버섯을 분쇄하여 액체 배양을 할 경우에는 꽃송이 버섯의 특유 효능이 사라질 수 있다.The present invention is followed by dry fermentation after inoculation of lactic acid bacteria in oyster mushroom. Dry fermentation made in a solid state is advantageous because the present invention uses the extracts of the flower mushrooms, and if the flower mushrooms are pulverized and cultured in liquid, the specific efficacy of the flower mushrooms may disappear.
본 발명에 따른 건식 발효는 채취한 꽃송이 버섯에 유산균, 바람직하게는 락토바실러스 플란타룸을 1×105 내지 1×1010 CFU/g, 바람직하게는 1×108 내지 1×109 CFU/g의 농도로 접종한 후, 40℃ 내지 60℃에서 20시간 내지 24시간 동안, 바람직하게는 40℃ 내지 50℃에서 22 내지 24시간 동안 수행할 수 있다. Dry fermentation according to the present invention is performed by adding lactic acid bacteria, preferably Lactobacillus plantarum, to the collected cauliflower mushrooms 1×10 5 to 1×10 10 CFU/g, preferably 1×10 8 to 1×10 9 CFU/g After inoculation at a concentration of g, it can be carried out at 40°C to 60°C for 20 to 24 hours, preferably at 40°C to 50°C for 22 to 24 hours.
상기 건식 발효 후, 발효가 끝난 꽃송이 버섯을 세척하고 건조시킨 후, 배전 및 분쇄하는 과정을 수행한다. 본 발명에서는 유산균 발효된 꽃송이 버섯을 100℃ 내지 200℃에서 3분 내지 5분간 배전한 후 그라인더로 분쇄하여 입자를 제조한다. 상기 분쇄를 통해 꽃송이 버섯의 표면적을 넓혀 물과의 접촉 면적을 증대시킴으로써 꽃송이 버섯을 추출하기 용이한 상태로 만들 수 있다.After the dry fermentation, the process of roasting and pulverizing is performed after the fermented oyster mushroom is washed and dried. In the present invention, the lactic acid bacteria fermented oyster mushroom is roasted at 100 ° C. to 200 ° C. for 3 to 5 minutes, and then pulverized with a grinder to prepare particles. Through the pulverization, the surface area of the blossom mushroom is increased to increase the contact area with water, thereby making it easy to extract the blossom mushroom.
이후, 상기 수득된 꽃송이 버섯 분말을 물로 추출하여 유산균 발효 꽃송이 버섯 추출물을 수득하는 단계를 수행하게 된다.Thereafter, the step of obtaining a lactic acid bacterium fermented flower mushroom extract is performed by extracting the obtained oyster mushroom powder with water.
본 발명에 따른 상기 커피원두 추출물은, 전체 100 중량부 기준으로 발아커피원두 추출물 1 중량부 내지 15 중량부 및 유산균 발효된 꽃송이 버섯 추출물 5 중량부 내지 20 중량부를 포함할 수 있다. 또는, 상기 커피원두 추출물은, 전체 100 중량부 기준으로 발아커피원두 추출물 2.5 중량부 내지 12.5 중량부 및 유산균 발효된 꽃송이 버섯 추출물 7.5 중량부 내지 17.5 중량부를 포함할 수 있다. 상기 커피원두 추출물은 발아커피원두 추출물 및 유산균 발효된 꽃송이 버섯 추출물의 혼합 추출물은 바람직하게는 전체 100 중량부를 기준으로 15 중량부 내지 25 중량부, 더욱 바람직하게는 20 중량부로 포함되는 것이 커피 본연의 풍미 및 향을 유지하는 동시에 발아커피원두에서의 항염 및 항산화 효능과 상기 유산균 발효된 꽃송이 버섯 추출물의 항암, 항염, 항산화 및 면역력 강화의 효능을 극대화시킬 수 있다.The coffee bean extract according to the present invention may include 1 part by weight to 15 parts by weight of the germinated coffee bean extract and 5 parts by weight to 20 parts by weight of the lactic acid bacterium fermented blossom mushroom extract based on 100 parts by weight in total. Alternatively, the coffee bean extract may include 2.5 parts by weight to 12.5 parts by weight of the germinated coffee bean extract and 7.5 parts by weight to 17.5 parts by weight of the lactic acid bacterium fermented blossom mushroom extract based on 100 parts by weight of the total. The coffee bean extract is preferably contained in an amount of 15 to 25 parts by weight, more preferably 20 parts by weight, based on 100 parts by weight, of the mixed extract of the germinated coffee bean extract and the lactic acid bacterium fermented flower mushroom extract. While maintaining flavor and aroma, it is possible to maximize the anti-inflammatory and antioxidant effects of germinated coffee beans and the anti-cancer, anti-inflammatory, antioxidant, and immune-enhancing effects of the lactic acid bacteria-fermented chrysanthemum extract.
본 발명에 따른 기능성 커피 조성물은, 전술한 바와 같이 하기 중 하나 이상의 특성을 포함할 수 있다.The functional coffee composition according to the present invention, as described above, may include one or more of the following properties.
i) 항암;i) anticancer;
ii) 항염;ii) anti-inflammatory;
iii) 항균;iii) antibacterial;
iv) 항산화; 및iv) antioxidant; and
v) 면역력 강화.v) strengthening immunity.
상기 기능성과 관련된 특성에 대한 내용은 후술하는 실시예에서 구체적으로 설명한다.The content related to the functionality will be described in detail in Examples to be described later.
본 발명은, 또한 캡슐 커피의 제조방법에 관한 것이다.The present invention also relates to a method for preparing coffee capsules.
상기 캡슐 커피의 제조방법은, 상기 기능성 커피 조성물을 캡슐(capsule)에 충진시키고, 상기 캡슐의 캡을 씌워 내부 성분이 유출되지 않도록 밀봉하는 단계를 포함할 수 있다.The method for producing coffee capsules may include filling a capsule with the functional coffee composition, and sealing the capsule so that internal components do not leak by covering the capsule with a cap.
본 발명에 따른 캡슐 커피의 제조방법에서 상기 밀봉은 1bar 내지 20bar의 기압을 넣어서, 수행하는 것을 특징으로 할 수 있다. 또는, 상기 밀봉의 경우 1bar 내지 15bar, 바람직하게는 5bar 내지 15bar의 기압으로 수행될 수 있다. 본 발명에 따른 기능성 커피 조성물은 높은 압력에서도 안정성이 높기 때문에 상기 기압 범위 내에서 밀봉함으로써 포장 가공이 되어도 무방하기 때문에, 캡슐 커피 제품이 추출되면서 캡슐이 터지거나 갈라지는 등의 부작용을 방지할 수 있다.In the method for producing coffee capsules according to the present invention, the sealing may be performed by putting an air pressure of 1 bar to 20 bar. Alternatively, the sealing may be performed at an atmospheric pressure of 1 bar to 15 bar, preferably 5 bar to 15 bar. Since the functional coffee composition according to the present invention has high stability even at high pressure, it may be packaged by sealing within the above atmospheric pressure range, so side effects such as bursting or cracking of the capsule while the coffee capsule product is extracted can be prevented.
특별히 제한되지 않으나, 예를 들어, 상기 기능성 커피 조성물은, 액상 또는 분말 형태로 상기 캡슐 커피 제조방법에 사용될 수 있다.Although not particularly limited, for example, the functional coffee composition may be used in the capsule coffee manufacturing method in liquid or powder form.
본 발명은, 또한, 전술한 캡슐 커피의 제조방법으로 제조된 캡슐 커피에 관한 것이다.The present invention also relates to capsule coffee prepared by the method for producing capsule coffee described above.
상기 캡슐 커피는, 통상적으로 알려진 금속, 플라스틱 또는 합성수지로 제조된 캡슐 처럼 생기 용기 내부에 분말 또는 액상의 커피 원재료가 포함되는 것을 의미할 수 있고, 파드(Pod) 형태를 포함할 수 있다.The coffee capsule may mean that the raw material of coffee powder or liquid is included in the vitality container like a capsule made of a commonly known metal, plastic or synthetic resin, and may include a pod form.
상기 파드(pod)라 함은, 인체에 무해한 천연 종이 부직포 펄프에 1잔 분량의 원두를 담아 사용하는 것으로, 원두를 분쇄하는 탬핑 공정을 포함하여 별도의 공정 등이 필요없고, 캡슐 커피에서 혹시 있을지 모르는 알루미늄 또는 플라스틱 성분 등의 환경 호르몬의 유해성을 방지할 수 있는 형태를 말한다. 상기 파드(pod)의 종류로는 크게 탬핑되어 있는 정도를 기준으로, "하드 파드" 및 "소프트 파드"로 구분할 수 있으며, 상기 "하드 파드"는 에스프레소를 추출할 수 있도록 분쇄된 원두를 단단하게 압출시켜 천연 펄프로 감싼 형태이고, 상기 "소프트 파드"는, 전술한 '하드 파드'와 담는 형태는 동일하지만, 단단하게 탬핑되어 있지 않고 소프트하게 들어 있어 드립 커피를 추출하는데 사용될 수 있다. The pod refers to the use of one cup of coffee beans in a natural paper non-woven pulp that is harmless to the human body. It refers to a form that can prevent the harmful effects of environmental hormones such as aluminum or plastic components that are not known. As the type of the pod, it can be divided into "hard pod" and "soft pod" based on the degree of tamping, and the "hard pod" hardens the ground coffee beans so that espresso can be extracted. It is extruded and wrapped in natural pulp, and the "soft pod" has the same content as the aforementioned 'hard pod', but it is not tamped hard and is soft, so it can be used to extract drip coffee.
상기 캡슐 커피 및 파드의 경우, 본 발명에 따른 기능성 커피 조성물을 포함함으로써, 꽃송이버섯을 포함하되 상기 꽃송이버섯에 대한 유산균 발효를 시킨 꽃송이버섯에 대한 추출물을 포함하고, 추가적으로 제황수를 이용하여 발아시킨 발아커피원두 추출물을 포함함으로써, 커피 본연의 풍미나 향은 유지하면서 동시에 보다 항암, 항염, 항산화 및 면역력 강화 등의 효능이 높은 커피를 제공할 수 있다.In the case of the coffee capsules and pods, by including the functional coffee composition according to the present invention, the extract for the oyster mushroom, which was fermented with lactic acid bacteria for the oyster mushroom, and additionally germinated using sulfuric water By including the germinated coffee bean extract, it is possible to provide coffee with higher efficacy, such as anti-cancer, anti-inflammatory, antioxidant and immune enhancement, while maintaining the original flavor or aroma of coffee.
이하, 본 발명을 구체적인 실험예를 통하여 보다 상세하게 설명한다. 그러나 이들 실험예는 본 발명을 예시적으로 설명하기 위한 것으로 본 발명의 범위가 이들 실험예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail through specific experimental examples. However, these experimental examples are for illustrative purposes only and the scope of the present invention is not limited to these experimental examples.
[제조예 1] 발아커피원두 추출물의 제조[Preparation Example 1] Preparation of germinated coffee bean extract
커피생두를 고루 펼친 상태에서 0.5㎛의 분쇄 광물 유황 0.2 중량% 및 정제수 99.8 중량%를 혼합한 제황수를 하루 동안 4번 내지 5번 정도 살수하여 발아시킨 발아커피원두에 대하여 이를 세척, 건조 및 로스팅 후 분쇄시킨 분쇄 발아커피원두를 얻었다. 이후, 상기 분쇄 발아커피원두를 온도 100℃의 물을 첨가하여 추출하여 발아커피원두 추출물을 수득하였다.Washing, drying, and roasting germinated coffee beans that were germinated by spraying green coffee beans evenly distributed with 0.5 μm of pulverized mineral sulfur and 0.2 wt% of purified water and 99.8 wt% of purified water 4 to 5 times a day. Then, pulverized germinated coffee beans were obtained. Thereafter, the ground germinated coffee beans were extracted by adding water at a temperature of 100° C. to obtain a germinated coffee bean extract.
[제조예 2] 유산균 발효 꽃송이 버섯 추출물의 제조[Preparation Example 2] Preparation of lactic acid bacteria fermented oyster mushroom extract
본 제조예 2에는 한국생명공학연구원의 유전자은행(Korean Collection for Type Cultures, KCTC, Jeongeup, Korea)으로부터 분양 받은 락토바실러스 플란타룸 KCTC3108 (이하, L. 플란타룸) 균주를 사용하였다.In this Preparation Example 2, the Lactobacillus plantarum KCTC3108 (hereinafter, L. plantarum) strain received from the Gene Bank (Korean Collection for Type Cultures, KCTC, Jeongeup, Korea) of the Korea Research Institute of Bioscience and Biotechnology was used.
L. 플란타룸의 초기 배양을 위해 먼저 MRS 배지(Difco, Detroit, MI, USA)를 사용하였다. L. 플란타룸을 MRS 배지 5㎖에 접종하여 인큐베이터 (SIF500, Jeiotech, Inc., Daejeon, Korea)에서 24시간 동안 배양한 후 멸균 생리식염수 (NaCl 8.5g/L)로 수세하여 동일한 용액 5㎖에 희석하였다. 이어서 희석액 2㎖를 상기 식용 배지 200㎖에 접종한 후 37℃, 100rpm에서 다시 24시간 동안 증균 배양하였다. 배양액을 4℃, 3500rpm에서 10분간 원심분리(Combi 514R, Hanil scientific, Inc., Gimpo, Korea)하여 배지를 제거한 후 동결건조 (FDV-7006, Operon-80, Gimpo, Korea)하여 -70℃에서 보관하였다.For the initial culture of L. plantarum, MRS medium (Difco, Detroit, MI, USA) was used first. L. plantarum was inoculated into 5 ml of MRS medium and cultured for 24 hours in an incubator (SIF500, Jeiotech, Inc., Daejeon, Korea), washed with sterile physiological saline (NaCl 8.5 g/L), and 5 ml of the same solution diluted in Then, 2 ml of the dilution was inoculated into 200 ml of the edible medium, and then enriched and cultured for 24 hours at 37° C. and 100 rpm. The culture medium was centrifuged at 4℃, 3500rpm for 10 minutes (Combi 514R, Hanil scientific, Inc., Gimpo, Korea) to remove the medium, and then freeze-dried (FDV-7006, Operon-80, Gimpo, Korea) at -70℃ kept.
그 후, 출원인이 직접 채취한 꽃송이 버섯을 사용하여, 먼저 발효에 필요한 수분을 흡수시키기 위하여, 꽃송이 버섯 300g에 멸균증류수 30㎖을 첨가하여 40℃에서 4시간 동안 침지하였다. 이어서 꽃송이 버섯 무게를 기준으로 각각 2%, 5% 및 10%(w/w)의 글루코스를 첨가하고, L. 플란타룸 분말을 1×109 CFU/g의 동일한 농도로 접종하여 40℃에서 24시간 동안 발효하였다. 발효가 끝난 꽃송이 버섯을 멸균 증류수로 2회 세척한 후 오븐(OF-02G, Jeiotech, Inc., Daejeon, Korea)을 사용하여 50℃에서 24시간 동안 건조하였다.After that, using the oyster mushroom directly collected by the applicant, 30 ml of sterile distilled water was added to 300 g of oyster mushroom and immersed for 4 hours at 40° C. in order to absorb the moisture required for fermentation. Then, 2%, 5%, and 10% (w/w) of glucose were added based on the weight of the flower mushroom, respectively, and L. plantarum powder was inoculated at the same concentration of 1×10 9 CFU/g at 40°C. Fermented for 24 hours. After the fermentation was completed, the oyster mushroom was washed twice with sterile distilled water, and then dried at 50° C. for 24 hours using an oven (OF-02G, Jeiotech, Inc., Daejeon, Korea).
그런 다음, 건조가 끝난 꽃송이 버섯을 오븐에 다시 넣어 220℃에서 내부 온도가 100℃로 떨어질 때까지 약 3분간 방치한 후 온도를 다시 200℃까지 상승시키면서 약 3분간 배전하였다. 배전된 꽃송이 버섯에 대한 추출은 2㎜ 크기로 분쇄하고, 분쇄한 꽃송이 버섯 250g을 2L의 정제수를 이용하여 10시간 동안 추출하였다. 추출이 끝난 시료를 -4℃에서 냉장보관 후 하기 커피원두 추출물 제조에 사용하였다.Then, after drying, the dried oyster mushroom was put back into the oven and left for about 3 minutes from 220°C until the internal temperature dropped to 100°C, and then roasted for about 3 minutes while raising the temperature again to 200°C. Extraction of the roasted oyster mushroom was crushed to a size of 2 mm, and 250 g of the pulverized oyster mushroom was extracted using 2L of purified water for 10 hours. After the extraction was completed, the sample was refrigerated at -4°C and used to prepare the following coffee bean extract.
[제조예 3] 커피원두 추출물의 제조[Preparation Example 3] Preparation of coffee bean extract
제조예 1로부터 수득된 발아커피원두 추출물과 유산균 발효된 꽃송이 버섯 추출물을 아래와 [표 1]과 같은 혼합 비율로 혼합하여 커피원두 추출물을 최종 제조하였다.The coffee bean extract was finally prepared by mixing the germinated coffee bean extract obtained in Preparation Example 1 and the lactic acid bacterium fermented flower mushroom extract at the mixing ratio as shown in Table 1 below.
구분(단위: g)Category (unit: g) 실시예Example 비교예comparative example
1One 22 33 44 55 1One 22 33 44 55
발아커피원두추출물Germinated coffee bean extract 2.52.5 55 7.57.5 1010 12.512.5 0.10.1 -- 15.515.5 1616 2323
유산균 발효된 꽃송이 버섯 추출물Lactobacillus Fermented Blossom Mushroom Extract 17.517.5 1515 12.512.5 1010 7.57.5 2121 2323 33 3.53.5 --
[실험예 1] DPPH 라디칼 소거활성 측정[Experimental Example 1] Measurement of DPPH radical scavenging activity
본 발명에 따른 기능성 커피 조성물이 항산화 효능이 있는지 여부를 확인하기 위하여, 항산화 활성 측정 실험 중 하나인 DPPH(1,1-diphenyl-2-picrylhydrazyl) 라디칼 소거능 측정법을 사용하였다. 상기 DPPH 라디칼 소거활성 측정법은 항산화질의 전자공여능으로 인해 방향족 화합물 및 방향족 아민류에 의해 환원되어 자색이 탈색되는 정도를 나타내는 정도를 지표로 하여 항산화능을 측정하는 방법이다.In order to confirm whether the functional coffee composition according to the present invention has antioxidant efficacy, one of the antioxidant activity measurement experiments, DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging activity measurement method was used. The DPPH radical scavenging activity measurement method is a method of measuring antioxidant activity by using the degree of decolorization of purple due to the reduction by aromatic compounds and aromatic amines due to the electron donating ability of antioxidants as an index.
보다 구체적으로, 실시예 1 내지 5 및 비교예 1 내지 5로부터 제조된 커피원두 추출물 각각을 에탄올과 혼합하여 농도별로 2㎖씩 제조하여 200μM의 DPPH 용액 1㎖를 첨가한 후 반응액을 완전히 섞기 위해서 10초간 vortexing한 다음, 실온에서 30분간 반응시켰다. 남아있는 DPPH의 양을 측정하기 위해서 UV-vis spectrophotometer (852A Diode Array Spectrophotometer, Hewlett Packard)를 이용하여 517㎚에서 흡광도를 측정하였다.More specifically, each of the coffee bean extracts prepared in Examples 1 to 5 and Comparative Examples 1 to 5 was mixed with ethanol to prepare 2 ml of each concentration, 1 ml of a 200 μM DPPH solution was added, and then the reaction solution was completely mixed. After vortexing for 10 seconds, the reaction was carried out at room temperature for 30 minutes. In order to measure the amount of DPPH remaining, absorbance was measured at 517 nm using a UV-vis spectrophotometer (852A Diode Array Spectrophotometer, Hewlett Packard).
측정한 결과는 하기 표 2에 나타내었다.The measurement results are shown in Table 2 below.
구분division 농도별 자유 라디칼 소거능(%)Free radical scavenging ability by concentration (%)
농도(μM)Concentration (μM) 55 1010 2020 3030 4040 5050
실시예 1Example 1 2525 4343 6161 8181 9393 9898
실시예 2Example 2 2626 4242 5858 8282 9191 9797
실시예 3Example 3 2424 4444 5555 8080 9090 9696
실시예 4Example 4 2222 4444 5959 8484 8989 9797
실시예 5Example 5 2626 4141 6464 8585 8989 9595
비교예 1Comparative Example 1 1616 3131 4040 6161 6868 7878
비교예 2Comparative Example 2 1414 3333 4040 6363 6767 8181
비교예 3Comparative Example 3 1313 3030 4141 6060 6969 8080
비교예 4Comparative Example 4 1515 3333 4444 6363 6969 8484
비교예 5Comparative Example 5 1111 3030 4141 6060 6464 8080
본 발명에 따른 커피원두 추출물을 포함하는 기능성 커피 조성물의 경우 모든 실험군에서 농도 증가에 따라 항산화 활성이 증가하는 경향을 보였으며, 최고 농도인 50.0μM의 농도에서 95% 이상의 높은 DPPH 소거능을 나타내는 것을 확인할 수 있었다. In the case of the functional coffee composition containing the coffee bean extract according to the present invention, the antioxidant activity showed a tendency to increase as the concentration increased in all experimental groups, and it was confirmed that the highest concentration of 50.0 μM exhibited a high DPPH scavenging ability of 95% or more. could
[실험예 2] 대식세포를 이용한 nitric oxide(NO) 생성량 측정[Experimental Example 2] Measurement of nitric oxide (NO) production using macrophages
본 발명에 따른 기능성 커피 조성물이 항염 효능이 있는지 여부를 확인하기 위하여, 대식세포에서 nitric oxide(NO) 생성량을 측정하였다. 대식세포의 NOS(nitric oxide synthase)는 TNF-γ, TNF-α와 같은 여러 가지 사이토카인이나 LPS(E. coli 유래 lipopolysaccharide) 등 세균내독소의 영향을 받아 NOS 유전자가 발현 유도됨으로써 나타나기 때문에 이를 확인하고자 시료와 LPS를 단독 및 함께 투여함으로써 NO의 생성능을 확인하였다.In order to determine whether the functional coffee composition according to the present invention has anti-inflammatory effects, the amount of nitric oxide (NO) production in macrophages was measured. NOS (nitric oxide synthase) in macrophages is influenced by various cytokines such as TNF-γ and TNF-α or bacterial endotoxins such as LPS (E. coli-derived lipopolysaccharide). The ability to generate NO was confirmed by administering the sample and LPS alone or together.
NO 생성량 측정을 위해 사용된 세포주는 마우스 유래 J774.1 대식세포를 사용하였으며, 세포를 10% FBS와 RPMI 1640 배지에 배양하여 24-웰 플레이트에 4.5×10⁴cells/well의 농도로 넣은 다음, 실시예 1 내지 5 및 비교예 1 내지 5의 커피원두 추출물(sample, "Sam"으로 표시)로 각각 두 가지 군을 나누어 모두 37℃, 5% CO2 배양기에 48시간 동안 배양한 후, LPS(lipipilysaccharide)를 200ng/well의 농도로 처리하여 48시간 동안 세포를 배양하였다. 상등액 50μg을 취하여 동일 부피의 Griess시약(1% sulfanilamide/0.1% N-(1-naphthyl)-ethylenediamine dihtdrochloride/2.5% h3po4)을 첨가하여 실온에서 10분간 반응시킨 후, microplate reader를 이용하여 540nm의 흡광도를 측정하였다. Nitrite의 표준물질로는 sodium nitrite를 사용하였으며, 농도는 32μM에서부터 0.25μM까지 RPMI 1640 배지로 2배씩 희석하여 얻은 표준곡선과 비교하여 계산하였다.The cell line used for measurement of NO production was mouse-derived J774.1 macrophages, and the cells were cultured in 10% FBS and RPMI 1640 medium, put into a 24-well plate at a concentration of 4.5 × 10⁴cells/well, and then in Example Each of the two groups was divided into 1 to 5 and the coffee bean extracts of Comparative Examples 1 to 5 (sample, indicated as “Sam”), and all were cultured in an incubator at 37° C., 5% CO 2 for 48 hours, followed by LPS (lipipilysaccharide) was treated at a concentration of 200 ng/well and the cells were cultured for 48 hours. Take 50 μg of the supernatant, add the same volume of Griess reagent (1% sulfanilamide/0.1% N-(1-naphthyl)-ethylenediamine dihtdrochloride/2.5% h3po4), and react at room temperature for 10 minutes. Then, using a microplate reader, absorbance at 540 nm was measured. Sodium nitrite was used as a standard material for nitrite, and the concentration was calculated by comparing with a standard curve obtained by diluting twice with RPMI 1640 medium from 32 μM to 0.25 μM.
상기 측정 및 계산한 결과는 하기 표 3에 나타내었다.The measurement and calculation results are shown in Table 3 below.
구분division Nitric Oxide(㎛)Nitric Oxide(㎛)
LPSLPS 대조군control LPSLPS LPS+SamLPS+Sam SamSam
실시예 1Example 1 33 9.59.5 6.56.5 3.13.1
실시예 2Example 2 6.26.2 3.23.2
실시예 3Example 3 6.76.7 3.33.3
실시예 4Example 4 6.66.6 3.33.3
실시예 5Example 5 6.66.6 3.23.2
비교예 1Comparative Example 1 8.18.1 3.83.8
비교예 2Comparative Example 2 8.38.3 3.93.9
비교예 3Comparative Example 3 8.28.2 3.83.8
비교예 4Comparative Example 4 8.68.6 3.73.7
비교예 5Comparative Example 5 8.48.4 3.83.8
본 발명에 따른 커피원두 추출물을 포함하는 기능성 커피 조성물 각각을 단독으로 처리한 실험군에서는 NO 생성량이 대조군과 비교하여 큰 차이를 보이지 않았으나, 본 발명에 따른 커피원두 추출물을 포함하는 기능성 커피 조성물들을 LPS와 함께 처리한 실험군에서, LPS를 단독으로 처리한 9.5μM 보다, 낮은 NO 생성량을 보이는 것을 확인할 수 있었다. In the experimental group in which each of the functional coffee compositions containing the coffee bean extract according to the present invention was treated alone, the amount of NO production did not show a significant difference compared to the control group, but the functional coffee compositions containing the coffee bean extract according to the present invention were treated with LPS and In the experimental group treated together, it was confirmed that the NO production amount was lower than that of 9.5 μM treated with LPS alone.
[실험예 3] 암세포 증식 억제 측정[Experimental Example 3] Measurement of cancer cell proliferation inhibition
본 발명에 따른 커피원두 추출물을 포함하는 기능성 커피 조성물의 암세포 증식 억제를 측정하기 위하여, MTT 분석(methylthiazolyldiphenyl tetrazolium bromide assay)을 실시하였다.In order to measure the cancer cell proliferation inhibition of the functional coffee composition containing the coffee bean extract according to the present invention, MTT assay (methylthiazolyldiphenyl tetrazolium bromide assay) was performed.
구체적으로, 대장암 세포주 HCT116을 1 × 105 세포/웰(well)의 농도로 접종하고 96-웰에 10% fatal bovine serum(FBS)를 첨가한 DMEM/F-12배지에 대장암 세포주 HCT116을 1 × 105 세포/웰(well)의 농도로 96-웰에 각각 100㎕씩 첨가 후 24시간 세포배양하여 24시간 동안 5% CO2, 37℃의 인큐베이터(incubator)에서 배양한 후, 상기 실시예 1 내지 5 및 비교예 1 내지 5에서 제조한 커피원두 추출물 100㎎/㎖로 DMSO에 녹여진 샘플을 DMEM/F-12배지에 1:1000으로 희석해서 세포에 최종 100㎍/㎖ 주입하였다. 첨가 후 24시간 동안 추가 배양한 후 각 웰에 인산완충식염수(phosphate buffered saline, PBS)에 녹인 MTT (1㎎/㎖) 용액 50㎕씩 첨가하여 2시간 동안 다시 배양했다. 그 후 웰 바닥에 형성된 포르마잔(formazan)이 흩어지지 않게 상등액을 제거하고, 디메틸설폭사이드(dimethyl sulfoxide, DMSO)를 100㎕ 첨가하여 천천히 녹인 후, 자외선/가시광선 분광광도계(UV/Visible spectrophotometer;Human Cop., Xma-3000PC, Seoul, Korea)를 이용하여 540㎚에서 흡광도를 측정하여 HCT116의 생존률을 측정하였다.Specifically, the colon cancer cell line HCT116 was inoculated at a concentration of 1 × 10 5 cells/well, and the colorectal cancer cell line HCT116 was inoculated in DMEM/F-12 medium supplemented with 10% fatal bovine serum (FBS) in 96-well. After adding 100 μl of each to 96-well at a concentration of 1 × 10 5 cells/well, culturing the cells for 24 hours, 5% CO 2 , and culturing in an incubator at 37° C. for 24 hours, the above execution Samples dissolved in DMSO with 100 mg/ml of coffee bean extract prepared in Examples 1 to 5 and Comparative Examples 1 to 5 were diluted 1:1000 in DMEM/F-12 medium, and finally 100 μg/ml was injected into the cells. After additional incubation for 24 hours after addition, 50 μl of MTT (1 mg/ml) solution dissolved in phosphate buffered saline (PBS) was added to each well and incubated again for 2 hours. After that, the supernatant was removed so that the formazan formed on the bottom of the well was not dispersed, and 100 μl of dimethyl sulfoxide (DMSO) was added and dissolved slowly, followed by a UV/Visible spectrophotometer (UV/Visible spectrophotometer; The survival rate of HCT116 was measured by measuring absorbance at 540 nm using Human Cop., Xma-3000PC, Seoul, Korea).
상기 측정한 결과는 도 1에 나타내었다.The measurement results are shown in FIG. 1 .
도 1에서 확인할 수 있는 바와 같이, 본 발명에 따른 커피원두 추출물을 포함하는 기능성 커피 조성물은, 대장암세포(HCT116)의 생존률을 감소시키는 점, 즉 암세포 증식 어제 효능이 있음을 확인하였다.As can be seen in FIG. 1 , it was confirmed that the functional coffee composition comprising the coffee bean extract according to the present invention has an effect in reducing the survival rate of colorectal cancer cells (HCT116), that is, cancer cell proliferation yesterday.
추가적으로, In vivo에서 암을 잘 유발한다고 알려져 있는 murine B16F10 melanoma세포를 C57BL/6J mouse의 복강에 주사하여 암을 발생시킨 후, 암 발생 7일 전부터 매일 200㎎/kg으로 커피 원두 추출물을 먹이면서 mouse의 tumor volume(종양의 부피)을 21일 간 측정하여, 도 2에 나타내었다. 이 경우, 실시예 3의 커피 원두 추출물을 먹였으며, 대조군으로는 비교예 5의 커피 원두 추출물을 사용하였다.Additionally, murine B16F10 melanoma cells, which are known to cause cancer in vivo, were injected into the abdominal cavity of C57BL/6J mice to induce cancer. The tumor volume (the volume of the tumor) was measured for 21 days, and is shown in FIG. 2 . In this case, the coffee bean extract of Example 3 was fed, and the coffee bean extract of Comparative Example 5 was used as a control.
도 2에서 확인할 수 있는 바와 같이, 비교예 5의 커피 원두 추출물을 먹은 mouse(대조군)의 경우, B16F10 세포를 주사한 지 15일 이후부터 급격하게 종양의 부피가 증가하였지만. 실시예 3의 커피 원두 추출물을 먹은 mouse(실험군)의 경우 종양의 부피가 크게 증가하지 않음을 알 수 있었다.As can be seen in FIG. 2 , in the case of the mouse (control group) that ate the coffee bean extract of Comparative Example 5, the tumor volume increased rapidly from 15 days after injection of B16F10 cells. In the case of mice (experimental group) that ate the coffee bean extract of Example 3, it was found that the tumor volume did not significantly increase.
[실험예 4] TNF-α assay[Experimental Example 4] TNF-α assay
감염된 미생물의 방어를 위해 대식세포(macrophage)가 분비하는 대표적인 사이토카인으로 TNF-α가 알려져 있다. 따라서, 본 발명에 따른 커피원두 추출물을 포함하는 기능성 커피 조성물의 면역력 관련 효능을 확인하기 위하여, TNF-α 분석은 Invitrogen(Carlsbad, CA, USA)의 TNF-α kit를 사용하였다. Raw 264.7 세포를 96 well plate에 1 × 104cells/well로 분주 후에 24시간 동안 배양시킨 다음 Raw 264.7 세포주에 β-glucan을 1, 5, 10, 20, 40, 80, 160, 320, 640, 1280㎍/㎖의 농도로 처리하여 24시간 동안 배양한 후 상등액을 취하였다. 상등액 중 10㎕를 취하여 TNF-α antibody-coated 처리된 96 well plate에 옮긴 후 standard diluents buffer와 biotinylated antiTNF-α solution을 각각 20㎕ 첨가한 후 90분간 실온에서 배양하였다. 배양 후, wash buffer를 이용하여 4번 세척한 후 steptavidin-HRP 100㎕를 첨가하고 30분간 실온에서 반응시켰다. 이를 4번 세척한 후 stabilized chromogen을 각 well에 100㎕ 첨가한 후, 차광하여 30분간 실온에서 반응시켰다. TNF-α is known as a representative cytokine secreted by macrophages for the defense of infected microorganisms. Therefore, in order to confirm the immunity-related efficacy of the functional coffee composition comprising the coffee bean extract according to the present invention, TNF-α analysis was performed using the TNF-α kit of Invitrogen (Carlsbad, CA, USA). Raw 264.7 cells were seeded in 96 well plates at 1 × 10 4 cells/well, and then cultured for 24 hours. After treatment with a concentration of 1280㎍ / ㎖ and cultured for 24 hours, the supernatant was taken. 10 μl of the supernatant was transferred to a 96 well plate treated with TNF-α antibody-coated, 20 μl of standard diluents buffer and biotinylated antiTNF-α solution were added, respectively, and incubated at room temperature for 90 minutes. After incubation, after washing 4 times using wash buffer, 100 μl of steptavidin-HRP was added and reacted at room temperature for 30 minutes. After washing 4 times, 100 μl of stabilized chromogen was added to each well, and then reacted at room temperature for 30 minutes after blocking light.
각 well에 stop solution 100㎕를 첨가한 후, 실시예 1의 커피 원두 추출물을 첨가한 후의 TNF-α 분비량에 대하여 β-glucan을 첨가한 후의 TNF-α 분비량과 비교하기 위하여 도 2에 나타내었다.After adding 100 μl of stop solution to each well, the amount of TNF-α secretion after adding the coffee bean extract of Example 1 is shown in FIG. 2 to compare with the amount of TNF-α secretion after adding β-glucan.
각 well에 stop solution 100㎕를 첨가한 후, 실시예 1 내지 5 및 비교예 1 내지 5 각각에 대하여 30분 이내로 ELISA-reader(Bio-Rad Laboratories Inc.)를 이용하여 450 nm에서 측정하였다.After adding 100 μl of a stop solution to each well, each of Examples 1 to 5 and Comparative Examples 1 to 5 was measured at 450 nm using an ELISA-reader (Bio-Rad Laboratories Inc.) within 30 minutes.
상기 측정한 결과는 하기 표 4에 나타내었다.The measurement results are shown in Table 4 below.
구분division absorbance(%)absorbance (%)
농도(㎍/㎖)Concentration (μg/ml) Control Control 1010 2020 4040 8080 100100 200200
실시예 1Example 1 8080 6868 7575 8080 8282 8888 9494
실시예 2Example 2 6767 7474 8181 8484 8686 9595
실시예 3Example 3 6666 7676 8282 8585 8989 9797
실시예 4Example 4 6666 7272 8383 8686 8888 9595
실시예 5Example 5 6060 7575 8181 8585 8787 9696
비교예 1Comparative Example 1 5151 6161 6868 7070 7171 8080
비교예 2Comparative Example 2 5555 6666 6767 7373 7474 8282
비교예 3Comparative Example 3 5353 6262 7070 7474 7777 8383
비교예 4Comparative Example 4 5151 6161 7171 7171 7676 8484
비교예 5Comparative Example 5 4949 6060 6767 7070 7171 8181
상기 표 4에서 확인할 수 있는 바와 같이, 본 발명에 따른 커피원두 추출물을 포함하는 기능성 커피 조성물을 첨가할 경우, TNF-α의 분비는 저농도부터 농도 유의적으로 증가하다 TNF-α의 생산이 증가한 것으로부터 macrophage인 Raw 264.7 세포를 활성화시킴으로써, 면역 강화 효과가 충분히 있다고 사료된다.As can be seen in Table 4 above, when the functional coffee composition comprising the coffee bean extract according to the present invention is added, the secretion of TNF-α is significantly increased from the low concentration, indicating that the production of TNF-α is increased. By activating Raw 264.7 cells, which are macrophages, it is considered that there is sufficient immune-enhancing effect.
[실험예 5] 관능성 평가[Experimental Example 5] Sensory evaluation
상기 실시예 1 내지 5 및 비교예 1 내지 5로부터 제조된 커피원두 추출물을 포함하는 기능성 커피 조성물에 뜨거운 물로 1:20으로 희석하여 관능성 평가 테스트를 진행하였다.The functional coffee composition comprising the coffee bean extract prepared in Examples 1 to 5 and Comparative Examples 1 to 5 was diluted 1:20 with hot water to perform a sensory evaluation test.
관능성 평가 테스트는 일반인 20명을 대상으로 진행하였으며, 특히 쓴맛에 따른 선호도에 따라 상중하 등급을 나누어 이루어졌다.The sensory evaluation test was conducted on 20 ordinary people, and in particular, the upper, middle and lower grades were divided according to the preference according to the bitter taste.
상기 관능성 평가 테스트에 대한 결과는 표 5에 나타내었다.The results of the sensory evaluation test are shown in Table 5.
구분division 관능성 평가 결과Sensory evaluation results
실시예 1Example 1 ○○○○
실시예 2Example 2
실시예 3Example 3 ○○○○
실시예 4Example 4 ○○○○
실시예 5Example 5
비교예 1Comparative Example 1
비교예 2Comparative Example 2 ××
비교예 3Comparative Example 3 ××××
비교예 4Comparative Example 4
비교예 5Comparative Example 5 ××
○○ : 선호도 "상"이 15명 이상인 경우○ : 선호도 "상"이 10명 이상인 경우△ : 선호도 "상"이 5명 이상이고, 선호도 "중'이 10명 이상인 경우× : 선호도 "하"가 10명 이상인 경우×× : 선호도 "하"가 15명 이상인 경우○○: When the preference “high” is 15 or more ○: When the preference “high” is 10 or more △: When the preference “high” is 5 or more, and the preference “medium” is 10 or more ×: Preference “low” In the case of 10 or more people ××: When the preference “lower” is 15 or more people
전술한 본원의 설명은 예시를 위한 것이며, 본원이 속하는 기술분야의 통상의 지식을 가진 자는 본원의 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 쉽게 변형이 가능하다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다. 예를 들어, 단일형으로 설명되어 있는 각 구성 요소는 분산되어 실시될 수도 있으며, 마찬가지로 분산된 것으로 설명되어 있는 구성 요소들도 결합된 형태로 실시될 수 있다.The above description of the present application is for illustration, and those of ordinary skill in the art to which the present application pertains will understand that it can be easily modified into other specific forms without changing the technical spirit or essential features of the present application. Therefore, it should be understood that the embodiments described above are illustrative in all respects and not restrictive. For example, each component described as a single type may be implemented in a dispersed form, and likewise components described as distributed may also be implemented in a combined form.
본원의 범위는 상기 상세한 설명보다는 후술하는 특허청구범위에 의하여 나타내어지며, 특허청구범위의 의미 및 범위 그리고 그 균등 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본원의 범위에 포함되는 것으로 해석되어야 한다.The scope of the present application is indicated by the following claims rather than the above detailed description, and all changes or modifications derived from the meaning and scope of the claims and their equivalents should be construed as being included in the scope of the present application.

Claims (10)

  1. 커피원두 추출물을 포함하는 기능성 커피 조성물에 있어서,In the functional coffee composition comprising a coffee bean extract,
    상기 커피원두 추출물은 제황수를 이용하여 발아시킨 발아커피원두 추출물 및 유산균 발효된 꽃송이 버섯 추출물을 포함하고,The coffee bean extract includes a germinated coffee bean extract germinated using sulfuric water and a lactic acid bacterium fermented flower mushroom extract,
    상기 조성물은, 하기 중 하나 이상의 특성을 포함하는 기능성 커피 조성물;The composition comprises a functional coffee composition comprising one or more of the following properties;
    i) 항암;i) anticancer;
    ii) 항염;ii) anti-inflammatory;
    iii) 항균;iii) antibacterial;
    iv) 항산화; 및iv) antioxidant; and
    v) 면역력 강화.v) strengthening immunity.
  2. 제 1 항에 있어서, 상기 제황수는 광물 유황을 세척하여 준비하는 단계;The method of claim 1, wherein the sulfurization water is prepared by washing mineral sulfur;
    상기 준비된 광물 유황을 0.5㎛ 이하로 분쇄하는 단계; 및pulverizing the prepared mineral sulfur to 0.5 μm or less; and
    상기 분쇄된 광물 유황을 정제수와 혼합하는 단계를 포함하는 제황수 제조방법에 의해 제조된 것을 특징으로 하는 기능성 커피 조성물. Functional coffee composition, characterized in that it is prepared by a method for producing sulfuric water comprising the step of mixing the pulverized mineral sulfur with purified water.
  3. 제 1 항에 있어서, 상기 발아커피원두 추출물은, According to claim 1, wherein the germinated coffee bean extract,
    1) 커피 생두를 고루 펼친 상태에서 0.3㎛ 또는 0.5㎛의 분쇄 광물 유황 0.1 중량% 또는 0.2 중량% 각각에 대하여 정제수 99.9 중량% 및 99.8 중량%를 혼합하여 혼합물을 제조하는 단계;1) preparing a mixture by mixing 99.9 wt% and 99.8 wt% of purified water with respect to 0.1 wt% or 0.2 wt% of ground mineral sulfur of 0.3 μm or 0.5 μm, respectively, in a state in which green coffee beans are evenly spread;
    2) 상기 제조된 혼합물에 제황수를 하루 동안 4번 또는 5번 정도 살수하여 발아시킨 발아커피원두를 제조하는 단계;2) preparing germinated coffee beans by sprinkling the prepared mixture with sulfuric water 4 or 5 times a day;
    3) 상기 제조된 발아커피원두를 세척, 건조 및 로스팅 후 분쇄시켜 커피원두를 제조하는 단계; 및3) washing, drying and roasting the prepared germinated coffee beans and then grinding them to prepare coffee beans; and
    4) 상기 제조된 커피원두를 온도 90℃ 또는 150℃의 물을 첨가하여 추출하여 커피원두 추출물을 제조하는 단계를 포함하는 발아커피원두 추출물 제조방법에 의해 제조된 것을 특징으로 하는 기능성 커피 조성물.4) A functional coffee composition, characterized in that it is prepared by a method for producing a germinated coffee bean extract comprising the step of extracting the prepared coffee beans by adding water at a temperature of 90°C or 150°C to prepare a coffee bean extract.
  4. 제 1 항에 있어서, 상기 유산균 발효된 꽃송이 버섯 추출물은, The method according to claim 1, wherein the lactic acid bacteria fermented chrysanthemum mushroom extract,
    1) 꽃송이 버섯에 멸균 증류수를 첨가하여 발효에 필요한 수분을 흡수시키는 단계;1) adding sterile distilled water to the cypress mushroom to absorb moisture required for fermentation;
    2) 단계 1)에서 수득된 꽃송이 버섯에 글루코스를 첨가하고 유산균을 접종하여 건식 발효를 수행하는 단계;2) performing dry fermentation by adding glucose to the flower mushroom obtained in step 1) and inoculating lactic acid bacteria;
    3) 발효가 끝난 꽃송이 버섯를 세척하고 건조시킨 후 배전 및 분쇄하는 단계; 및3) washing, drying, roasting and pulverizing the fermented Zinnia mushrooms; and
    4) 단계 3)에서 수득된 꽃송이 버섯 분말을 물로 추출하여 유산균 발효 꽃송이 버섯 추출물을 수득하는 단계를 포함하는 유산균 발효된 꽃송이 버섯 추출물 제조방법에 의해 제조된 것을 특징으로 하는 기능성 커피 조성물.4) Functional coffee composition, characterized in that it is prepared by a method for producing a lactic acid bacteria fermented cherry blossom mushroom extract comprising the step of extracting the flower mushroom powder obtained in step 3) with water to obtain a lactic acid bacteria fermented flower mushroom extract.
  5. 제 4 항에 있어서, 상기 2) 단계는 락토바실러스 플란타룸 (Lactobacillus plantarum), 락토바실러스 람노서스 (Lactobacillus rhamnosus), 락토바실러스 에시도필러스 (Lactobacillus acidophilus), 락토바실러스 불가리커스 (Lactobacillus bulgaricus), 바실러스 코아그란스 (Bacillus coagulans), 및 비피도박테리아 롱검 (BifidobacteriumLongum)으로 이루어진 군으로부터 선택된 1종 이상의 유산균으로 발효한 것을 특징으로 하는 기능성 커피 조성물.According to claim 4, wherein step 2) is Lactobacillus plantarum (Lactobacillus plantarum), Lactobacillus rhamnosus (Lactobacillus rhamnosus), Lactobacillus acidophilus (Lactobacillus acidophilus), Lactobacillus bulgaricus (Lactobacillus), Bacillus coagulans (Bacillus coagulans), and Bifidobacterium Longum (Bifidobacterium Longum) Functional coffee composition, characterized in that fermented with one or more lactic acid bacteria selected from the group consisting of.
  6. 제 1 항에 있어서, 상기 커피원두 추출물은, 전체 100 중량부 기준으로 발아커피원두 추출물 1 중량부 내지 15 중량부 및 유산균 발효된 꽃송이 버섯 추출물 5 중량부 내지 20 중량부를 포함하는 것을 특징으로 하는 기능성 커피 조성물. The functional according to claim 1, wherein the coffee bean extract comprises 1 to 15 parts by weight of the germinated coffee bean extract and 5 to 20 parts by weight of the lactic acid bacterium fermented blossom mushroom extract based on 100 parts by weight of the total. coffee composition.
  7. 제 1 항 또는 제 6 항 중 어느 한 항에 따른 기능성 커피 조성물을 캡슐(capsule)에 충진시키고, 상기 캡슐의 캡을 씌워 내부 성분이 유출되지 않도록 밀봉하는 단계를 포함하는 캡슐 커피의 제조방법. A method for producing coffee capsules, comprising the step of filling a capsule with the functional coffee composition according to any one of claims 1 to 6, and sealing the capsule so that the internal components do not leak by covering the capsule.
  8. 제 7 항에 있어서, 상기 기능성 커피 조성물은, 액상 또는 분말 형태인 것을 특징으로 하는 캡슐 커피의 제조방법.The method according to claim 7, wherein the functional coffee composition is in liquid or powder form.
  9. 제 7 항에 있어서, 상기 밀봉은 1bar 내지 20bar의 기압을 넣어서, 수행하는 것을 특징으로 하는 캡슐 커피의 제조방법.The method of claim 7, wherein the sealing is performed by putting an air pressure of 1 bar to 20 bar.
  10. 제 7 항 내지 제 9 항 중 어느 한 항에 따른 캡슐 커피의 제조방법으로 제조된 캡슐 커피.[Claim 10] Coffee capsules prepared by the method for producing coffee capsules according to any one of claims 7 to 9.
PCT/KR2020/015675 2020-08-24 2020-11-10 Functional coffee composition and capsule coffee comprising same WO2022045452A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020200106152A KR20220025979A (en) 2020-08-24 2020-08-24 Functional coffee composition and capsule coffee comprising the same
KR10-2020-0106152 2020-08-24

Publications (1)

Publication Number Publication Date
WO2022045452A1 true WO2022045452A1 (en) 2022-03-03

Family

ID=80353384

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2020/015675 WO2022045452A1 (en) 2020-08-24 2020-11-10 Functional coffee composition and capsule coffee comprising same

Country Status (2)

Country Link
KR (1) KR20220025979A (en)
WO (1) WO2022045452A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004350621A (en) * 2003-05-30 2004-12-16 Unitika Ltd Food prepared by lactic fermentation of sparassis crispa
KR20140138490A (en) * 2013-05-24 2014-12-04 배영재 Fermented Sparassis crispa and method for preparing the same
US20170259989A1 (en) * 2012-11-12 2017-09-14 2266170 Ontario Inc. Beverage Capsule And Process And System For Making Same
KR20190085666A (en) * 2018-01-11 2019-07-19 네오라이프 주식회사 Composition having the function of both anti-oxidation and immunity and alcoholic beverage including the same
KR20200090466A (en) * 2019-01-21 2020-07-29 박승재 Process for the production of Cauliflower fermented coffee.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2697179C (en) 2009-03-27 2015-06-23 Kraft Foods Global Brands Llc Coffee composition
KR101520332B1 (en) 2014-07-09 2015-05-14 최재영 Functional coffee having medicinal herb and manufacturing method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004350621A (en) * 2003-05-30 2004-12-16 Unitika Ltd Food prepared by lactic fermentation of sparassis crispa
US20170259989A1 (en) * 2012-11-12 2017-09-14 2266170 Ontario Inc. Beverage Capsule And Process And System For Making Same
KR20140138490A (en) * 2013-05-24 2014-12-04 배영재 Fermented Sparassis crispa and method for preparing the same
KR20190085666A (en) * 2018-01-11 2019-07-19 네오라이프 주식회사 Composition having the function of both anti-oxidation and immunity and alcoholic beverage including the same
KR20200090466A (en) * 2019-01-21 2020-07-29 박승재 Process for the production of Cauliflower fermented coffee.

Also Published As

Publication number Publication date
KR20220025979A (en) 2022-03-04

Similar Documents

Publication Publication Date Title
US11122830B2 (en) Antioxidant producing bacterium and uses thereof
WO2017119795A1 (en) Novel lactobacillus casei gfc1 strain, fermented ginseng extract using strain, and preparation method thereof
WO2011010770A1 (en) Novel lactobacillus plantarum and composition comprising same
WO2014007427A1 (en) Method using enzyme conversion and lactobacillus fermentation for preparing concentrated fermented red ginseng liquid having enhanced compound k content, and product containing concentrated fermented red ginseng liquid prepared by said preparation method as active ingredient
WO2017074037A1 (en) Novel strain derived from traditional fermented food and having excellent enzyme productivity, and method for preparing fermented cereal enzyme food by using same
WO2014193014A1 (en) Nano-sized kimchi lactic acid bacteria
WO2023055188A1 (en) Novel probiotics and use thereof
WO2023014037A1 (en) Method for extracting moringa leaves, and food composition comprising extract thereof
WO2016072655A1 (en) Composition for improvement, treatment or prevention of constipation comprising cassia seed lactic acid bacteria fermented product as effective ingredient, and method for preparing same
WO2010131783A1 (en) Fermented aloe product, preparation method therefor and functional food products using same
WO2022045452A1 (en) Functional coffee composition and capsule coffee comprising same
KR101972236B1 (en) New Lactobacillus plantarum isolated from KIMCHI and uses thereof
WO2024048934A1 (en) Novel lactic acid lactiplantibacillus plantarum sko-001 bacterium for reducing body fat, and uses thereofhh
WO2024071624A1 (en) Composition for preventing or relieving alcoholic liver damage comprising kiwi-fermented product
KR102097509B1 (en) Novel lactic acid bacteria and method of preparing fermented product having effect of anti-obesity and anti-diabets using the same
WO2019083289A1 (en) Sorghum and red bean fermentation product having efficacy of bowel health and bowel improvement and method for producing same
WO2023282655A1 (en) Composition for promoting and improving sleep, beverage containing same, and preparation method therefor
WO2019093651A1 (en) Method for preparing fermented-green-tea extract and fermented-green-tea extract prepared thereby
WO2021071159A1 (en) Antidiabetic, hypotensive, or antioxidant composition comprising yeast fermentate of rhynchosia nulubilis and method for preparing same composition
WO2022124569A1 (en) Method for preparing fermented antler extract by three-step processing
KR102152356B1 (en) A composition for treating atopic disease comprising a fermented product of black rice bran by bioconversion
WO2021080298A1 (en) Composition containing enteroccocus faecalis as active ingredient for preventing or treating obesity or metabolic syndromes induced thereby
KR102221579B1 (en) NOVEL STRAIN OF Lactobacillus buchneri AND USE THEREOF
WO2021040086A1 (en) Novel lactic acid bacteria, and composition and health functional food, each comprising same
WO2015167240A1 (en) Composition containing scutellaria alpina extract

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20951682

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20951682

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 14.11.2023)